Mutations in the gene encoding the tRNA processing endonuclease (ELAC2, hereafter referred to as RNaseZ) are linked to the early onset of CM symptoms (Haack et al., 2013; Shinwari et al., 2017). The gene discussed is ELAC2; the disease is cutaneous mastocytosis.